BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced positive results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback